Optimal cytoreduction for advanced epithelial ovarian cancer

QR Code

Optimal cytoreduction for advanced epithelial ovarian cancer

This article is review of literature on role of surgery in the initial management of advanced stage ovarian cancer, focusing on the definition of optimum surgical cytoreduction, assessment of resectability, estimation of the risk of postoperative complications. Analyze of published scien- tific data...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. G. Kormosh, K. P. Laktionov, N. S. Kerzhkovskaya
Format:	Article
Language:	Russian
Published:	ABV-press 2014-08-01
Series:	Опухоли женской репродуктивной системы
Subjects:	ovarian cancer stage iii-iv surgical cytoreduction
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/278
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience)
by: N. G. Kormosh, et al.
Published: (2014-07-01)

REPEATED OPTIMAL CYTOREDUCTIVE SURGERIES IN COMBINED MODALITY TREATMENT OF OVARIAN CANCER. CASE REPORT
by: S. V. Molchanov, et al.
Published: (2017-07-01)

MANAGEMENT IN EARLY OVARIAN CANCER: STANDARDS AND UNSOLVED PROBLEMS
by: N. G. Kormosh, et al.
Published: (2014-09-01)

Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
by: M. V. Zabelin, et al.
Published: (2022-06-01)

Systemic and tumor-specific inflammatory markers VCAM-1 and ICAM-1 as indicators of extent of surgery and oncologic outcome in advanced ovarian cancer
by: Okan Gultekin, et al.
Published: (2025-09-01)

Optimizing the primary treatment of patients with advanced ovarian cancer
by: S. O. Nikogosyan, et al.
Published: (2016-11-01)

THE VALUE OF CYTOREDUCTIVE SURGERY FOR ISOLATED LYMPH NODE RECURRENCE OF OVARIAN CANCER
by: H. I. Mamajonov, et al.
Published: (2020-07-01)

EXPERIENCE IN APPLYING THE TECHNOLOGY OF CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS
by: A. V. Shelekhov, et al.
Published: (2018-07-01)

Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review)
by: E. V. Sibirskaya, et al.
Published: (2024-05-01)

Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?
by: Bhatt Aditi, et al.
Published: (2024-07-01)

Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study
by: Hua-Hsi Wu, et al.
Published: (2025-08-01)

Cytoreductive surgery and hyperthermal intraperitoneal chemoperfusion in colorectal cancer and cancer of ovaries: our experience and perspectives of a new method
by: A. V. Malynovskyi, et al.
Published: (2020-10-01)

Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
by: S. A. Kuznetsov, et al.
Published: (2015-09-01)

DISSEMINATED OVARIAN CANCER: SURGICAL TREATMENT (LITERATURE REVIEW)
by: S. V. Molchanov, et al.
Published: (2016-02-01)

Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
by: D. D. Morikov, et al.
Published: (2022-05-01)

Analysis of the effectiveness of primary treatment of stage IA–IIA ovarian cancer
by: V. N. Zhurman, et al.
Published: (2024-11-01)

Predicting the outcome of cytoreductive surgery in patients with advanced ovarian cancer
by: M. G. Yakovleva, et al.
Published: (2023-06-01)

Bevacizumab in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Risk-Stratified Analysis
by: İrem Öner, et al.
Published: (2025-06-01)

HIPEC application potential in the treatment of extensive carcinomatosis in ovarian cancer (retrospective study)
by: S. I. Radostev, et al.
Published: (2024-06-01)

USE OF INTEGRATED DIFFUSION-WEIGHTED MAGNETIC-RESONANCE IMAGING IN PRE-OPERATIVE EVALUATION OF RESECTABILITY OF ADVANCED OVARIAN CANCER
by: A. E. Solopova, et al.
Published: (2017-08-01)

Management of Advanced Ovarian Cancer: Current Clinical Practice and Future Perspectives
by: Dimitrios Papageorgiou, et al.
Published: (2025-06-01)

Comparative analysis of the diagnostyc value of CT and MRI in the assessment of peritoneal carcinomatosis in ovarian cancer
by: Yu. A. Soloveva, et al.
Published: (2025-03-01)

Optimizing patient recovery: prospective study evaluating compliance and clinical outcomes of enhanced recovery protocols in ovarian cancer following cytoreductive surgery with HIPEC
by: Somashekhar S. P., et al.
Published: (2025-05-01)

Modern clinical portrait of ovarian cancer patient in the Novosibirsk region
by: A. V. Tarkhov, et al.
Published: (2025-03-01)

Evaluating the tozzi classification system in diaphragm surgeries for advanced ovarian cancer: Clinical applicability and perioperative outcomes
by: Divya Panyam Vuppu, et al.
Published: (2025-01-01)

Management and results of treatment of patients with refractory ovarian cancerr
by: N. G. Kormosh, et al.
Published: (2014-08-01)

Analysis of the impact of cytoreductive surgery in patients with oligometastatic renal cell carcinoma in clinical practice
by: D. V. Semenov, et al.
Published: (2024-03-01)

DIAGNOSTIC VALUE OF ULTRASOUND EXAMINATION IN PREOPERATIVE STAGING OF DISSEMINATED OVARIAN CANCER
by: N. V. Vyatkina, et al.
Published: (2016-10-01)

Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer
by: D. D. Morikov, et al.
Published: (2019-11-01)

Specific features of current intraperitoneal therapy in patients with ovarian cancer
by: A. G. Kedrova, et al.
Published: (2016-06-01)

EPITHELIAL OVARIAN CANCER. CLINICAL LECTURE
by: A. E. Solopova, et al.
Published: (2016-10-01)

Remote results of treatment of patients with advanced ovarian cancer after interval and delayed cytoreductive surgery: a retrospective single-center study
by: P. I. Sorokin, et al.
Published: (2025-05-01)

Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment
by: N. G. Kormosh, et al.
Published: (2014-07-01)

CLINICAL CASE OF MULTIMODALITY TREATMENT OF METASTATIC BLADDER CANCER
by: A. V. Lykov, et al.
Published: (2020-01-01)

Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement
by: Yu. A. Ragulin, et al.
Published: (2016-06-01)

Outcomes and prognostic factors of cytoreductive surgery and perioperative intraperitoneal chemotherapy in high-volume peritoneal carcinomatosis
by: Lee S. Kyang, et al.
Published: (2022-12-01)

Efficacy of adjunctive periodontal interventions in non-surgical periodontal therapy for Stage III/IV Grade C periodontitis: A systematic review and network meta-analysis
by: Shih-Ying Lin, et al.
Published: (2025-12-01)

NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER. MODERN METHODS AND PATIENTS SELECTION CRITERIA
by: A. E. Solopova, et al.
Published: (2016-09-01)

Proteomics in the diagnosis of ovarian cancer
by: V. E. Shevchenko, et al.
Published: (2014-07-01)

Recent Developments in Rare Ovarian Carcinosarcoma: Literature Review and Case Report
by: Alexandra Nienhaus, et al.
Published: (2025-05-01)